학술논문

Gp96-Ig/costimulator (OX40L, ICOSL, or 4-1BBL) combination vaccine improves T-cell priming and enhances immunity, memory, and tumor elimination
Document Type
Article
Source
In: Cancer Immunology Research. (Cancer Immunology Research, September 2016, 4(9):766-778)
Subject
Language
English
ISSN
23266074
23266066